BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Clozapine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Clozapine\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04580134-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Clozapine: Phase 4 readout est. (NCT04580134)
DESCRIPTION:Clozapine\, phase 4\, Schizophrenia.\nStudy: CLOZAPINE Response
  in Biotype-1\nEstimated primary completion: 30 April 2027. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/clozapine#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT04580134
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06456983-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Clozapine: Phase na readout est. (NCT06456983)
DESCRIPTION:Clozapine\, phase na\, Schizophrenia.\nStudy: Maintenance Elect
 roConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIS
 T Trial\nEstimated primary completion: July 2027. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/clozapine#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT06456983
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06634641-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Clozapine: Phase 4 readout est. (NCT06634641)
DESCRIPTION:Clozapine\, phase 4.\nStudy: Clozapine-related Immunodeficiency
  in Parkinsons Disease\nEstimated primary completion: September 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/clozapine#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT06634641
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT02639702-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Clozapine: Phase 4 readout est. (NCT02639702)
DESCRIPTION:Clozapine\, phase 4\, Schizophrenia.\nStudy: Switching From Twi
 ce-Daily to Once-Daily Clozapine Dosing in Schizophrenia\nEstimated primar
 y completion: 30 September 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/clozapine#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT02639702
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05958875-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Clozapine: Phase 4 readout est. (NCT05958875)
DESCRIPTION:Clozapine\, phase 4\, Schizophrenia.\nStudy: The Effect of a Si
 x Week Intensified Pharmacological Treatment for Schizophrenia Compared to
  Treatment as Usual in Subjects Who Had a First-time Treatment Failure on 
 Their First-line Treatment.\nEstimated primary completion: 30 June 2028. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/clozapine#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT05958875
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05208190-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Clozapine: Phase 4 readout est. (NCT05208190)
DESCRIPTION:Clozapine\, phase 4\, Schizophrenia.\nStudy: Clozapine for the 
 Prevention of Violence in Schizophrenia: a Randomized Clinical Trial\nEsti
 mated primary completion: 30 June 2028. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/clozapine#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT05208190
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07817069-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Clozapine: Phase na readout est. (NCT07817069)
DESCRIPTION:Clozapine\, phase na\, Schizophrenia.\nStudy: Effects of Nitrar
 ia Retusa Infusion on Clozapine-induced Metabolic Side Effects\nEstimated 
 primary completion: December 2028. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/clozapine#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07817069
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05316883-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Clozapine: Phase 4 readout est. (NCT05316883)
DESCRIPTION:Clozapine\, phase 4\, Schizophrenia.\nStudy: Biomarkers in Cloz
 apine-responding Schizophrenia\nEstimated primary completion: 31 December 
 2029. This is a ClinicalTrials.gov estimate\, not a confirmed readout date
 \, and it can move.\nDrug page: https://assetmemo.bio/drug/clozapine#upcom
 ing-events\nRegistry record: https://clinicaltrials.gov/study/NCT05316883
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06969755-9199@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20300730
DTEND;VALUE=DATE:20300731
SUMMARY:Clozapine: Phase 4 readout est. (NCT06969755)
DESCRIPTION:Clozapine\, phase 4\, Schizophrenia.\nStudy: Biomarkers to Enha
 nce Early Schizophrenia Treatment\nEstimated primary completion: 30 July 2
 030. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\
 , and it can move.\nDrug page: https://assetmemo.bio/drug/clozapine#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT06969755
URL:https://assetmemo.bio/drug/clozapine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
